# Lecture 02: Stimulants and Sedatives

## Neurotransmitter Basics

### VMAT (Vesicular Monoamine Transporter)
- **VMAT1/VMAT2** transport monoamine neurotransmitters into vesicles for release
- Critical for packaging dopamine, serotonin, norepinephrine

### Serotonin Pathway
- Derived from **tryptophan**
- Packaged into **VMAT1/2**
- Reuptake via **SERT**
- Breakdown via **MAO**

### MAO and COMT
- Function to break down **dopamine** and **serotonin** (MAO only for 5-HT)

---

## Stimulants

### Cocaine
- **MOA**: Blocks reuptake of monoamines (non-selective)
- Potent DA reuptake inhibitor

### Phenylethylamines

| Drug | Key Features |
|------|--------------|
| **Amphetamine** | Main phenylethylamine; intracellular effects + trace amine interactions |
| **Methamphetamine** | Higher ratio of central:peripheral effects |
| **MDMA** | Derivative of methamphetamine |
| **Methylphenidate** | Similar to amphetamine |

**Amphetamine vs Cocaine**: Amphetamines have **predominance of intracellular effects**

### Phenylethylamine Uses
- Narcolepsy
- ADD/ADHD
- Depression
- Weight loss/BED/Obesity

### Other Stimulants

| Drug | Use |
|------|-----|
| **Ephedrine** | Perioperative vasopressor |
| **Pseudoephedrine** | Decongestant |
| **Modafinil** | Narcolepsy |
| **Phentermine** | Weight loss |

### Tyramine
- Found in aged cheeses, wine, fermented foods
- Can cause **hypertensive/adrenergic crises** in patients taking MAOIs

---

## Adenosine System

### Adenosine Receptors

| Receptor | Effect |
|----------|--------|
| **A1, A2a** | Decrease cardiac oxygen demand, promote sleep |
| **A2b, A3** | Bronchospasm, inflammation |

### Methylxanthines (Adenosine Antagonists)
- **Caffeine** and **Theobromine**
- Effects: Bronchodilation, increased HR, CNS stimulation

---

## Nicotine
- **MOA**: Nicotinic ACh receptor **agonist**
- Low doses: Euphoria, arousal, relaxation, improved attention, appetite suppression
- High doses: Central respiratory paralysis, severe hypotension

---

## Sedatives and Hypnotics

### Definitions
- **Sedative**: Agent that reduces anxiety
- **Hypnotic**: Agent that produces drowsiness or maintains sleep

### Sleep Disorder Causes
- **LOW** melatonin
- **LOW** GABA
- **HIGH** orexin
- **HIGH** histamine

---

## Alpha-2 Agonists

Decrease sympathetic activation

| Drug | Primary Use |
|------|-------------|
| **Guanfacine** | ADHD |
| **Dexmedetomidine** | Sedation |
| **Clonidine** | Blood pressure |
| **Tizanidine** | Pain/Muscle relaxation |

---

## Benzodiazepines

### Mechanism
- **GABAa agonists** that increase the **frequency** of channel opening
- Naming: End in **-zepam** or **-ozlam**

### Properties
- Anxiolysis/sedation
- Anticonvulsant
- Muscle relaxant

### Problems with Chronic Use
1. **Tolerance**
2. **Dependence**
3. **Abuse potential**
4. **Withdrawal** (insomnia, anxiety, increased HR, seizures)

### Selectivity
- **Temazepam** and **Flurazepam**: Most selective for alpha-1 (sleep)
- Alpha-2: Better for anxiety

### Reversal
- **Flumazenil** (GABAa antagonist) - also works for alcohol

---

## Z-Drugs

### Mechanism
- Bind same site as benzodiazepines
- **Selective for GABAa with alpha-1 subunit**
- **LESS** dependence/abuse potential than benzos

### Drugs
- **Zolpidem**
- **Zaleplon**
- **Eszopiclone**

### Adverse Effects
- Complex sleep behaviors

---

## Melatonin System

### Mechanism
- MT1/MT2 receptors **inhibit** suprachiasmatic nucleus
- Leads to **activation** of VL preoptic nucleus → sleep

### Melatonin Agonists

| Drug | Indication |
|------|------------|
| **Ramelteon** | Difficulty with sleep onset |
| **Tasimelteon** | Non-24 hour sleep disorders (often blind patients) |

---

## Orexin Antagonists

| Drug | Indication |
|------|------------|
| **Suvorexant** | Sleep disorders |
| **Lemborexant** | Sleep disorders |

---

## Barbiturates

- **MOA**: Open chloride channel **without need for endogenous GABA**
- Most potent GABA agonists
- Indication: Anesthesia (rarely used now)

---

## Summary Table: Sedative Potency

| Class | Potency | MOA | Example | Dependence |
|-------|---------|-----|---------|------------|
| **Z-drugs** | Mildest | Selective α1-subunit | Zolpidem | Less |
| **Benzodiazepines** | Medium | ↑ GABA frequency | Lorazepam | More |
| **Barbiturates** | Most potent | Opens Cl⁻ without GABA | Phenobarbital | High |
